Navigation Links
Treating safety research like other clinical studies slows progress
Date:5/13/2008

Progress in patient safety research could slow to a crawl unless regulators work out a host of ethical issues, Johns Hopkins researchers assert in an upcoming opinion piece.

We cant apply a clinical paradigm to patient safety research. It just isnt the right fit, says Nancy Kass, Sc.D., deputy director for public health at the Johns Hopkins Berman Institute of Bioethics and an author of the article.

The piece, published in the June issue of The Joint Commission Journal on Quality and Patient Safety, was sparked by a 2006 study led by Peter Pronovost, M.D., Ph.D., professor of anesthesiology, critical care medicine, and surgery at the Johns Hopkins University School of Medicine. In the study, Pronovost, an expert on patient safety, implemented a checklist in intensive care units (ICUs) at 67 Michigan hospitals aimed at preventing bloodstream infections whenever doctors insert catheters.

The results were markedly positive: Bloodstream infections from catheters fell by two-thirds, and on average, infection rates in the ICUs went from 4 percent to zero. Over the course of the study, the program saved more than 1,500 lives and nearly $200 million.

Shortly after the studys results were published, however, an anonymous complaint led to a federal reexamination of the ethical oversight of the study. As in most human research, Pronovosts study had been reviewed by an institutional review board (IRB)an internal group required at most research institutions to use federal regulations to make sure research studies protect the welfare of human subjects.

Because Pronovosts study enforced safety measures already known to be effective, and because no data were ever collected from patients by name, the Johns Hopkins IRB classified Pronovosts study as exempt from further IRB review. This designation meant that informed consent was not necessary from the ICU patients and that IRB review from each of the 67 Michigan hospitals that part
'/>"/>

Contact: Christen Brownlee
cbrownlee@jhmi.edu
410-955-7832
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
2. Is 4 agents decoction (Si Wu Tang) efficacious in treating primary dysmenorrhea?
3. Treating diabetes during pregnancy can break link to childhood obesity
4. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
5. Treating Diabetes During Pregnancy Could Lead to Thinner Kids
6. Family-based treatment more effective than supportive psychotherapy in treating bulimia
7. Treating depression may improve recovery of heart rate variability following coronary syndromes
8. Antidepressant shows early promise in treating agitation and psychotic symptoms of dementia
9. Hospitals Improve Survival Rates While Treating Sicker Patients Thomson Healthcare Study Shows
10. Stem cells show promise for treating Huntingtons disease
11. Treating obstructive sleep apnea, preventing heart attacks and strokes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... 5 The first Football,for Hope Centre in ... its doors,today (5 December 2009). FIFA President Joseph ... Zille, 2010 FIFA World Cup Organising Committee,South Africa ... Kirsten Nematandani and Executive Mayor of the City ...
(Date:12/5/2009)... advanced Technology Center helps companies develop and test their cleaning processes. ... a variety of industries and solve problems for customers relating to ... ... December 5, 2009 -- Midbrook, Inc , a Jackson, MI-based ...
(Date:12/4/2009)... Investment Trust Inc. (NYSE: CRE ) ("Care" or ... a dividend of $0.17 per share of common stock. The ... record on December 14, 2009. ,, About ... real estate investment and finance company investing in healthcare-related real estate ...
(Date:12/4/2009)... Healthcare Trust of America, Inc. ("HTA"), a self-managed, ... a purchase and sale agreement to acquire a three ... Corsicana, Texas, and Fort Wayne, Indiana for approximately $20,500,000. ... the satisfaction of a number of conditions. ,, The ...
(Date:12/4/2009)... WASHINGTON, Dec. 4 In response to ... (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione ... Act (CSA), John Gay, executive director and ... the oldest and largest trade association ...
Breaking Medicine News(10 mins):Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2
... Scientific and Industrial Research Organization (CSIRO) may increase ... Stanton, Nutritionist. //Dr. Stanton has asked the Australian ... involved in recommending CSIRO diet as it contains ... to recommend the Australian Governments Australian Guide to ...
... of AIDS patients being robbed off their pockets to pay ... the service based health care system, // believed to prevail ... no AIDS related symptoms when she was admitted to the ... ensured prompt medical attention at the time of admission. She ...
... primary diseases affecting the children below two years. It is ... end of November and the incidence increases and reaches a ... MD, associate director of pediatric infectious diseases and HIV at ... the disease and this situation has to change. ...
... health in the UK could be hit by a shortage ... primary care reforms mean stalling of their careers and withdrawal ... trust mergers in England under Commissioning a Patient-led NHS has ... ,BMA public health doctors estimate as many as ...
... been named America's fittest city by Men's Fitness magazine, and ... the Men's Fitness magazine,// the top fittest cities behind Baltimore ... fattest cities behind Chicago were Las Vegas, Los Angeles, Dallas ... was ranked as the 25th fittest city on a list ...
... least five people-three in Ankara and two in Van-have tested positive ... Turkish official said on Sunday. They are on treatment.// ... the press that so far 28 people were tested at a ... total number of people infected with H5N1, the most virulent form ...
Other Medicine News:Health News:AIDS Patients Deceived By Private Health Care System In China 2Health News:Parental Knowledge Of RSV Infections Is Vital 2
(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense ... announced today the presentation of new data from the ... Protective Antigen (rPA) based anthrax vaccine is structurally stable ... to and including 55 degrees C. The data ...
(Date:12/4/2009)... cans and car trunks ,, WASHINGTON, Dec. 4 ... to defeat the Dorgan Importation plan encompassed in SA 2793. ... poised to open our borders, allowing our safe, closed drug ... We could soon be getting drugs that were stored ...
(Date:12/4/2009)... Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: ... testing of a novel integrated light source architecture for ... design raises the bar on imaging speed and overcomes ... light sources. This approach to optical engines builds ...
Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5MDMA Board Unanimously Opposes Medical Device Tax 5366 1MDMA Board Unanimously Opposes Medical Device Tax 5366 2Body Clock Blood Sugar Control Seem Linked 59234 1Body Clock Blood Sugar Control Seem Linked 59234 276 Children Dead From Swine Flu 3A CDC 59232 176 Children Dead From Swine Flu 3A CDC 59232 276 Children Dead From Swine Flu 3A CDC 59232 3
... Va., April 30 Innocoll, Inc., a ... three planned phase 2,clinical trials sponsored by ... investigate CollaRx(R) GENTAMICIN TOPICAL for the,treatment and ... commenced,dosing. CollaRx GENTAMICIN TOPICAL is a biodegradable ...
... CITY, Calif., April 29 Cardica, Inc.,(Nasdaq: ... Anastomosis,System achieved its primary endpoint in a large, ... made using the,PAS-Port system to conventional hand-sewn sutures ... the positive data from the trial,Cardica submitted a ...
Other Medicine Technology:Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Prevention of Diabetic Foot Infections 2Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Prevention of Diabetic Foot Infections 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Prevention of Diabetic Foot Infections 4Cardica Reports Positive Top-Line Results and Submits 510(k) for PAS-Port(R) Proximal Anastomosis System in Cardiac Bypass Surgery 2Cardica Reports Positive Top-Line Results and Submits 510(k) for PAS-Port(R) Proximal Anastomosis System in Cardiac Bypass Surgery 3Cardica Reports Positive Top-Line Results and Submits 510(k) for PAS-Port(R) Proximal Anastomosis System in Cardiac Bypass Surgery 4
1.0 mm long 120 degree angled tip with black ebonized shaft. Titanium handle with position reference indicator. Shaft length 52 mm, handle length 100 mm....
0.5 mm angled tip. Round knurled handle with dull finish. Tip angle: 130 degrees....
Angled for easy insertion into side port incision for manipulation of nucleus. Flat, paddle like tip for placement in groove to crack the nucleus for emulsification....
Straight shaft with 0.2 mm hour glass shape tip. Round knurled handle with dull finish. Manufactured in titanium....
Medicine Products: